Early-onset pancreatic cancer patients benefit more from neoadjuvant chemotherapy and surgery Post author:admin Post published:August 7, 2025 Post category:uncategorized The incidence of early-onset pancreatic cancer (EOPC) is rising, yet optimal treatment strategies remain unclear. You Might Also Like New study reveals long road to seizure control for people with focal epilepsy August 25, 2025 New study reveals unique metabolic function of lung-resident NK immune cells October 12, 2024 LHPP gene identified as a potential target for treatment-resistant depression November 2, 2023